Information and guidance from across SPS on pharmaceutical aspects of COVID-19 vaccines’ use

Guidance on use of COVID-19 vaccines in age specific groups and investigation and management of suspected cases of vaccine associated clotting problems.
In temporary vaccination sites, good medicines governance will ensure safe and secure handling. Key issues are listed and implementation tools are provided.
Guidance on dosing for all available COVID-19 vaccines - reference to the vaccine specific pages provides supplementary information
Guidance on preparing and administering common to all available COVID-19 vaccines, and specific to individual vaccines
Requirements specific to the Pfizer-BioNTech vaccine when used for the COVID-19 vaccination service within community pharmacy settings
Advice on appropriately transporting, storing, preparing and administering COVID-19 Vaccine Pfizer-BioNTech. Assumes the vaccine is received thawed.
Preparing vaccine using our SOPs, plus additional advice on diluent use, batch numbers, withdrawing additional doses and post-vaccination observation
The COVID-19 Vaccine Pfizer-BioNTech must be defrosted before use. This page gives guidance on considerations whilst thawing the vaccine.
Requirements specific to the AstraZeneca vaccine when used for the COVID-19 vaccination service within community pharmacy settings
Guidance on use of COVID-19 vaccines in age specific groups and investigation and management of suspected cases of vaccine associated clotting problems.
Advice on appropriately transporting, storing, preparing and administering COVID-19 Vaccine AstraZeneca for a "drive-through" model.
Preparing COVID-19 Vaccine AstraZeneca using our SOPs, plus additional advice on batch numbers, withdrawing additional doses and post-vaccination observation